Recent Articles

Bangor cancer fundraiser Irfon refused life-prolonging drugs

| February 28, 2015 | 0 Comments

Father-of-five Irfon Williams will have to move to England to receive cancer drug Cetuximab. Irfon Williams has raised almost £65,000 for charity Awyr Las since being diagnosed with cancer last year.

Continue Reading

Follow RoF

| February 28, 2015 | 0 Comments

The legendary Glamorous Solicitor showcases the style, the beauty and the sophistication for which the legal profession is so rightly known. A cancer charity has banned Irish firm Arthur Cox from giving it donations.

Continue Reading

Doctors with bad news seen as less compassionate

| February 27, 2015 | 0 Comments

Until recently, doctors and researchers believed that doctors who delivered bad news in an empathetic tone would be seen as sincere, said Dr.

Continue Reading

Community Leaders and Patients Dedicate Mount Sinai Queens Infusion Center

| February 27, 2015 | 0 Comments

Infusion Center treats cancer and blood disorders and now features private infusion bays, a nutrition station, and a totally renovated state-of-the-art interior

Continue Reading

Younger men more bothered after prostate cancer treatment

| February 27, 2015 | 0 Comments

By Shereen Lehman After treatment for localized prostate cancer, changes in quality of life will vary by age, as will men’s reactions to those changes, according to a new study. “While older and younger men start with different baseline quality of life function, older men may be less bothered by certain declines that may affect younger patients more,” Dr. Lindsay Hampson told Reuters Health in …

Continue Reading

Robert Benmosche, Former AIG CEO, Dies at Age 70

| February 27, 2015 | 0 Comments

He died on Friday at NYU Langone Medical Center in New York following treatment for lung cancer, AIG said in a statement.

Continue Reading

The V Foundation Reinforces its Fight Against Cancer with New and Extended Partnerships

| February 27, 2015 | 0 Comments

Several Nationwide Initiatives in March Offer Supporters Opportunities to Contribute (PRWeb February 27, 2015) Read the full story at http://www.prweb.com/releases/thevfoundation/marchpromotions/prweb12550316.htm

Continue Reading

New breast cancer test links immune 'hotspots' to better survival

| February 27, 2015 | 0 Comments

Scientists have developed a new test that can predict the survival chances of women with breast cancer by analyzing images of ‘hotspots’ where there has been a fierce immune reaction to a tumor. Researchers used statistical software previously used in criminology studies of crime hotspots to track the extent to which the immune system was homing in and attacking breast cancer cells.

Continue Reading

New breast cancer test links immune 'hotspots' to better survival

| February 27, 2015 | 0 Comments

Scientists have developed a new test that can predict the survival chances of women with breast cancer by analyzing images of 'hotspots' where there has been a fierce immune reaction to a tumor. Researchers used statistical software previously used in criminology studies of crime hotspots to track the extent to which the immune system was homing in and attacking breast cancer cells.

Continue Reading

U.S. Food and Drug Administration Accepts Biologics Licensing Application for Opdivo (nivolumab) for the Treatment of …

| February 27, 2015 | 0 Comments

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has accepted for filing and review the Biologics Licensing Application for Opdivo for the treatment of patients with advanced squamous non-small cell lung cancer after prior therapy.

Continue Reading